Development and validation of a ligand–receptor pairs signature to predict outcome and provide a therapeutic strategy in gastric cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–249. PubMed PMID: 33538338. DOI:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020 Mar;18(3):534–542. PubMed PMID: 31362118; PubMed Central PMCID: PMCPmc8859863. eng. DOI:10.1016/j.cgh.2019.07.045
   PubMed Web of Science ®Google Scholar
• Petryszyn P, Chapelle N, Matysiak-Budnik T. Gastric cancer: where are we heading? Dig Dis. 2020;38(4):280–285. DOI:10.1159/000506509. PubMed PMID: 32062657; eng.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet 202731. 2016 Nov 26;388(10060):2654–2664. PubMed PMID: 27156933; eng. DOI:10.1016/S0140-6736(16)30354-3
   PubMed Web of Science ®Google Scholar
• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700–713. PubMed PMID: 24618998; PubMed Central PMCID: PMC4019373. eng. DOI:10.1158/1055-9965.EPI-13-1057
   PubMed Web of Science ®Google Scholar
• Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep. 2019 Jun 24;21(8):67. DOI:10.1007/s11912-019-0820-4 PubMed PMID: 31236716; eng.
   PubMed Web of Science ®Google Scholar
• Ricci AD, Rizzo A, Brandi G. DNA damage response alterations in gastric cancer: knocking down a new wall. Future Oncol. 2021 Mar;17(8):865–868. PubMed PMID: 33508962; eng. DOI:10.2217/fon-2020-0989
   PubMed Web of Science ®Google Scholar
• Li K, Zhang A, Li X, et al. Advances in clinical immunotherapy for gastric cancer. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188615. PubMed PMID: 34403771; eng. DOI:10.1016/j.bbcan.2021.188615
   PubMed Web of Science ®Google Scholar
• Zeng D, Wu J, Luo H, et al. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer. J Immunother Cancer. 2021 Aug;9(8):e002467. PubMed PMID: 34376552; PubMed Central PMCID: PMC8356190. DOI:10.1136/jitc-2021-002467
   PubMed Web of Science ®Google Scholar
• Jiang H, Yu D, Yang P, et al. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing. Clin Transl Med. 2022 Feb;12(2):e730. PubMed PMID: 35184420. DOI:10.1002/ctm2.730
   PubMed Web of Science ®Google Scholar
• Ricci AD, Rizzo A, Rojas Llimpe FL, et al. Novel HER2-directed treatments in advanced gastric carcinoma: AnotHER paradigm shift? Cancers (Basel). 2021 Apr 1;13(7):1664. PubMed PMID: 33916206; PubMed Central PMCID: PMCPMC8036476. eng. DOI:10.3390/cancers13071664
   PubMed Web of Science ®Google Scholar
• Andor N, Graham TA, Jansen M. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nature Med. 2016 Jan;22(1):105–113. DOI:10.1038/nm.3984. PubMed PMID: 26618723.
   PubMed Web of Science ®Google Scholar
• Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature (69504). 2013 Sep 19;501(7467):328–337. DOI:10.1038/nature12624. PubMed PMID: 24048065; PubMed Central PMCID: PMCPMC4521623. eng.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang Y, Jia R, et al. Anti-PD-1 antibody SHR-1210 combined with apatinib for advanced hepatocellular carcinoma, gastric, or esophagogastric junction cancer: an open-label, dose escalation and expansion study. Clin Cancer Res. 2019 Jan 15;25(2):515–523. PubMed PMID: 30348638. DOI:10.1158/1078-0432.ccr-18-2484
   PubMed Web of Science ®Google Scholar
• Pietrantonio F, Randon G, Di Bartolomeo M, et al. Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials. ESMO Open (6883). 2021 Feb;6(1):100036. DOI:10.1016/j.esmoop.2020.100036. PubMed PMID: 33460964; PubMed Central PMCID: PMCPmc7815473. eng.
   PubMed Web of Science ®Google Scholar
• Viscardi G, Tralongo AC, Massari F, et al. Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis. Eur J Cancer. 2022 Dec;177:175–185. DOI:10.1016/j.ejca.2022.09.031. PubMed PMID: 36368251; eng.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Bernard V, Semaan A. Elucidation of tumor-stromal heterogeneity and the ligand-receptor interactome by single-cell transcriptomics in real-world pancreatic cancer biopsies. Clin Cancer Res. 2021 Nov 1;27(21):5912–5921. DOI:10.1158/1078-0432.ccr-20-3925. PubMed PMID: 34426439.
   PubMed Web of Science ®Google Scholar
• Ramilowski JA, Goldberg T, Harshbarger J, et al. A draft network of ligand–receptor-mediated multicellular signalling in human. Nat Commun. 2015 Jul 22;6(1):7866. DOI:10.1038/ncomms8866. PubMed PMID: 26198319; PubMed Central PMCID: PMCPmc4525178. eng.
   PubMedGoogle Scholar
• Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017 Feb 28;387:61–68. DOI:10.1016/j.canlet.2016.01.043. PubMed PMID: 26845449; eng.
   PubMed Web of Science ®Google Scholar
• McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell (66850). 2017 Feb 9;168(4):613–628. DOI:10.1016/j.cell.2017.01.018. PubMed PMID: 28187284; eng.
   PubMed Web of Science ®Google Scholar
• Rihawi K, Ricci AD, Rizzo A, et al. Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: novel translational implications. Int J Mol Sci. 2021 Apr 7;22(8):3805. DOI:10.3390/ijms22083805. PubMed PMID: 33916915; PubMed Central PMCID: PMCPMC8067563. eng.
   PubMed Web of Science ®Google Scholar
• Lin H, Xia L, Lian J, et al. Delineation of colorectal cancer ligand-receptor interactions and their roles in the tumor microenvironment and prognosis. J Transl Med. 2021 Dec 7;19(1):497. DOI:10.1186/s12967-021-03162-0. PubMed PMID: 34876143.
   PubMed Web of Science ®Google Scholar
• Eng KH, Ruggeri C, Müller R. Connecting prognostic ligand receptor signaling loops in advanced ovarian cancer. PLoS One (3752). 2014;9(9):e107193. DOI:10.1371/journal.pone.0107193. PubMed PMID: 25244152; PubMed Central PMCID: PMCPmc4171104. eng.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (66850). 2011 Mar 4;144(5):646–674. DOI:10.1016/j.cell.2011.02.013. PubMed PMID: 21376230; eng.
   PubMed Web of Science ®Google Scholar
• Soon WW, Hariharan M, Snyder MP. High-throughput sequencing for biology and medicine. Mol Syst Biol. 2013;9(1):640. DOI:10.1038/msb.2012.61. PubMed PMID: 23340846; PubMed Central PMCID: PMCPMC3564260. eng.
   PubMed Web of Science ®Google Scholar
• Le Gallo M, Lozy F, Bell DW. Next-generation sequencing. Adv Exp Med Biol. 2017;943:119–148. DOI:10.1007/978-3-319-43139-0_5. PubMed PMID: 27910067; eng.
   PubMed Web of Science ®Google Scholar
• Bao X, Shi R, Zhao T, et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC. Cancer Immunol Immunother. 2021 Jan;70(1):189–202. DOI:10.1007/s00262-020-02669-7. PubMed PMID: 32681241; eng.
   PubMed Web of Science ®Google Scholar
• Zhang M, Hu S, Min M, et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. 2021 Mar;70(3):464–475. DOI:10.1136/gutjnl-2019-320368. PubMed PMID: 32532891.
   Google Scholar
• Zhang Y, Wang D, Peng M, et al. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021 Mar 1;40(1):81. PubMed PMID: 33648534; PubMed Central PMCID: PMCPmc7919320. eng. DOI:10.1186/s13046-021-01874-1
   PubMed Web of Science ®Google Scholar
• Kumar MP, Du J, Lagoudas G, et al. Analysis of single-cell RNA-Seq identifies cell-cell communication associated with tumor characteristics. Cell Rep. 2018 Nov 6;25(6):1458–1468.e4. DOI:10.1016/j.celrep.2018.10.047. PubMed PMID: 30404002; PubMed Central PMCID: PMCPmc7009724. eng.
   PubMed Web of Science ®Google Scholar
• Zhang P, Yang M, Zhang Y, et al. Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer. Cell Rep. 2020 Mar 24;30(12);4317. DOI:10.1016/j.celrep.2020.03.020. PubMed PMID: 32209487; eng.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jensen MA, Zenklusen JC. A practical guide to the cancer genome atlas (TCGA). Methods Mol Biol. 2016;1418:111–141. DOI:10.1007/978-1-4939-3578-9_6. PubMed PMID: 27008012; eng.
   PubMedGoogle Scholar
• Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome bio. 2019 Dec 23;20(1):296. DOI:10.1186/s13059-019-1874-1. PubMed PMID: 31870423.
   PubMed Web of Science ®Google Scholar
• Wolock SL, Lopez R, Klein AM. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 2019 Apr 24;8(4):281–291 e9. DOI:10.1016/j.cels.2018.11.005. PubMed PMID: 30954476; PubMed Central PMCID: PMC6625319. eng.
   PubMed Web of Science ®Google Scholar
• Liu F, Wang P, Sun W, et al. Identification of ligand-receptor pairs associated with tumour characteristics in clear cell renal cell carcinoma. Front Immunol. 2022;13:874056. DOI:10.3389/fimmu.2022.874056. PubMed PMID: 35734169; PubMed Central PMCID: PMCPmc9207243. eng.
   PubMedGoogle Scholar
• Zhang P, Yang M, Zhang Y, et al. Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer. Cell Rep. 2019 May 7;27(6):1934–1947.e5. DOI:10.1016/j.celrep.2019.04.052. PubMed PMID: 31067475; eng.
   PubMed Web of Science ®Google Scholar
• Efremova M, Vento-Tormo M, Teichmann SA, et al. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020 Apr;15(4):1484–1506. DOI: 10.1038/s41596-020-0292-x. PubMed PMID: 32103204.
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics (6931). 2010 Jun 15;26(12):1572–1573. DOI:10.1093/bioinformatics/btq170. PubMed PMID: 20427518; PubMed Central PMCID: PMCPmc2881355. eng.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545–15550. DOI:10.1073/pnas.0506580102. PubMed PMID: 16199517; PubMed Central PMCID: PMCPmc1239896. eng.
   PubMed Web of Science ®Google Scholar
• Liberzon A, Birger C, Thorvaldsdóttir H, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015 Dec 23;1(6):417–425. DOI:10.1016/j.cels.2015.12.004. PubMed PMID: 26771021; PubMed Central PMCID: PMCPmc4707969. eng.
   PubMed Web of Science ®Google Scholar
• Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021 Aug 28;2(3):100141. DOI:10.1016/j.xinn.2021.100141. PubMed PMID: 34557778; PubMed Central PMCID: PMCPMC8454663. eng.
   PubMedGoogle Scholar
• Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnol. 2019 Jul;37(7):773–782. DOI:10.1038/s41587-019-0114-2. PubMed PMID: 31061481.
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1). DOI:10.1038/ncomms36122612. PubMed PMID: 24113773; PubMed Central PMCID: PMCPMC3826632. eng.
   PubMed Web of Science ®Google Scholar
• Thorsson V, Gibbs DL, Brown SD, et al. The immune landscape of cancer. Immunity (43474). 2018 Apr 17;48(4):812–830.e14. DOI:10.1016/j.immuni.2018.03.023. PubMed PMID: 29628290; PubMed Central PMCID: PMCPmc5982584. eng.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sethi NS, Hinoue T, et al. Comparative molecular analysis of gastrointestinal adenocarcinomas. Cancer Cell (38585). 2018 Apr 9;33(4);721–735.e8. DOI:10.1016/j.ccell.2018.03.010 . PubMed PMID: 29622466; PubMed Central PMCID: PMCPmc5966039. eng.
   PubMed Web of Science ®Google Scholar
• Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic signaling pathways in the cancer genome atlas. Cell (66850). 2018 Apr 5;173(2):321–337 e10. DOI:10.1016/j.cell.2018.03.035. PubMed PMID: 29625050; PubMed Central PMCID: PMC6070353. eng.
   PubMed Web of Science ®Google Scholar
• Takikawa O, Tagawa Y, Iwakura Y, et al. Interferon-gamma-dependent/independent expression of indoleamine 2,3-dioxygenase. Studies with interferon-gamma-knockout mice. Adv Exp Med Biol. 1999;467:553–557. DOI:10.1007/978-1-4615-4709-9_68. PubMed PMID: 10721099; eng.
   PubMed Web of Science ®Google Scholar
• Garcia-Diaz A, Shin DS, Moreno BH, et al. Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep. 2017 May 9;19(6):1189–1201. DOI:10.1016/j.celrep.2017.04.031. PubMed PMID: 28494868; PubMed Central PMCID: PMCPmc6420824. eng.
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu H, Li F, et al. The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer. Dig Dis Sci. 2013 Dec;58(12):3494–3502. DOI:10.1007/s10620-013-2837-0. PubMed PMID: 23979437; eng.
   PubMed Web of Science ®Google Scholar
• Chen JY, Li CF, Kuo CC, et al. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression. Breast Cancer Res. 2014 Jul 25;16(4):410. DOI:10.1186/s13058-014-0410-1. PubMed PMID: 25060643; PubMed Central PMCID: PMCPmc4220086. eng.
   PubMed Web of Science ®Google Scholar
• Danilova L, Ho WJ, Zhu Q, et al. Programmed cell death ligand-1 (PD-L1) and CD8 expression profiling identify an immunologic subtype of pancreatic ductal adenocarcinomas with favorable survival. Cancer Immunol Res. 2019 Jun;7(6):886–895. DOI:10.1158/2326-6066.cir-18-0822. PubMed PMID: 31043417.
   PubMed Web of Science ®Google Scholar
• Rooney MS, Shukla SA, Wu CJ, et al. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell (66850). 2015 Jan 15;160(1–2):48–61. DOI:10.1016/j.cell.2014.12.033. PubMed PMID: 25594174; PubMed Central PMCID: PMCPmc4856474. eng.
   PubMed Web of Science ®Google Scholar
• Masiero M, Simões FC, Han HD, et al. A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis. Cancer Cell (38585). 2013 Aug 12;24(2):229–241. DOI:10.1016/j.ccr.2013.06.004. PubMed PMID: 23871637; PubMed Central PMCID: PMCPmc3743050. eng.
   PubMed Web of Science ®Google Scholar
• Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet 202731. 2020 Aug 29;396(10251):635–648. DOI:10.1016/s0140-6736(20)31288-5. PubMed PMID: 32861308; eng.
   PubMed Web of Science ®Google Scholar
• Denton AE, Roberts EW, Fearon DT. Stromal cells in the tumor microenvironment. Adv Exp Med Biol. 2018;1060:99–114. DOI:10.1007/978-3-319-78127-3_6. PubMed PMID: 30155624; eng.
   PubMed Web of Science ®Google Scholar
• Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature (69504). 2017 Jan 18;541(7637):321–330. DOI:10.1038/nature21349. PubMed PMID: 28102259; eng.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu J, Huang W, et al. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J Transl Med. 2020 May 14;18(1):201. DOI:10.1186/s12967-020-02366-0. PubMed PMID: 32410620; PubMed Central PMCID: PMCPmc7226948. eng.
   PubMed Web of Science ®Google Scholar
• Wei J, Zeng Y, Gao X, et al. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer. BMC CANCER (4638). BMC Cancer. 2021 Nov 13;21(1):1221. DOI:10.1186/s12885-021-08975-2. PubMed PMID: 34774009; PubMed Central PMCID: PMCPmc8590758. eng.
   PubMed Web of Science ®Google Scholar
• Yang W, Niu L, Zhao X, et al. Pyroptosis impacts the prognosis and treatment response in gastric cancer via immune system modulation. Am J Cancer Res. 2022;12(4):1511–1534. PubMed PMID: 35530274; PubMed Central PMCID: PMCPmc9077078. eng.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang W, Jiang Y, et al. Identification of functional lncRnas in gastric cancer by integrative analysis of GEO and TCGA data. J Cell Biochem. 2019 Oct;120(10):17898–17911. DOI:10.1002/jcb.29058. PubMed PMID: 31135068; eng.
   PubMed Web of Science ®Google Scholar
• Sunakawa Y, Lenz HJ. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network. Curr Treat Options Oncol. 2015 Apr;16(4):17. DOI:10.1007/s11864-015-0331-y. PubMed PMID: 25813036; eng.
   PubMed Web of Science ®Google Scholar
• Yegin EG, Duman DG. Staging of esophageal and gastric cancer in 2014. Minerva Med. 2014 Oct;105(5):391–411. PubMed PMID: 25000218; eng.
   PubMed Web of Science ®Google Scholar
• Du F, Sun Z, Jia J, et al. Development and validation of an individualized nomogram for predicting survival in patients with esophageal carcinoma after resection. J Cancer. 2020;11(14):4023–4029. DOI:10.7150/jca.40767. PubMed PMID: 32368284; PubMed Central PMCID: PMCPmc7196250. eng.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Fu S, He T, et al. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis. Eur J Surg Oncol. 2018 Aug;44(8):1199–1204. DOI:10.1016/j.ejso.2018.04.011. PubMed PMID: 29784506; eng.
   PubMed Web of Science ®Google Scholar
• Kong G, Wang Y, Huang Y, et al. Identification and verification of tumor immune microenvironment-related prognostic genes in kidney renal clear cell carcinoma. Bio Med Res Int. 2022;2022:1–17. DOI:10.1155/2022/5563668. PubMed PMID: 35127943.
   Google Scholar
• Wang Y, Chen X, Jiang F, et al. A prognostic signature of pyroptosis-related lncRnas verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity. Front Genet. 2022;13:939439. DOI:10.3389/fgene.2022.939439. PubMed PMID: 36147488; PubMed Central PMCID: PMCPmc9485603. eng.
   PubMed Web of Science ®Google Scholar
• Yu K, Gu Y, Zhang P. Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. Br J Cancer. 2022 Nov;127(9):1709–1717. DOI:10.1038/s41416-022-01939-8. PubMed PMID: 36002752.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu J, Xu X, et al. Peritumoral TIGIT(+)CD20(+) B cell infiltration indicates poor prognosis but favorable adjuvant chemotherapeutic response in gastric cancer. Int Immunopharmacol. 2022 Jul;108:108735. DOI:10.1016/j.intimp.2022.108735. PubMed PMID: 35405596; eng.
   PubMed Web of Science ®Google Scholar
• Su X, Zhang J, Fu C. Recurrent metastatic penile cancer patient with positive PD-L1 expression obtained significant benefit from immunotherapy: a case report and literature review. 2020;13:3319–3324. DOI:10.2147/ott.s231258. PubMed PMID: 32368090.
   Google Scholar
• Li X, Liu L, Goodall GJ, et al. A novel single-cell based method for breast cancer prognosis. PLoS Comput Biol. 2020 Aug;16(8):e1008133. DOI:10.1371/journal.pcbi.1008133. PubMed PMID: 32833968; PubMed Central PMCID: PMCPMC7470419. eng.
   PubMed Web of Science ®Google Scholar
• Feng F, Tang F, Gao Y, et al. GenomicKB: a knowledge graph for the human genome. Nucleic Acids Res. 2023 Jan 6;51(D1):D950–d956 DOI:10.1093/nar/gkac957. PubMed PMID: 36318240; PubMed Central PMCID: PMCPMC9825430. eng.
   PubMedGoogle Scholar